Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Lythgoe

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Trials|March 18, 2016
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trialAlexander Häge, Tobias Banaschewski, Jan K Buitelaar, et al.
Biological Psychiatry|February 4, 2019
Hyperperfusion of Frontal White and Subcortical Gray Matter in Autism Spectrum DisorderBradley S Peterson, Ariana Zargarian, Jarod B Peterson, et al.
Human Brain Mapping|February 10, 2024
Spinal fMRI demonstrates segmental organisation of functionally connected networks in the cervical spinal cord: A test-retest reliability studyOlivia S Kowalczyk, Sonia Medina, Dimitra Tsivaka, et al.
Human Brain Mapping|July 26, 2016
Making use of longitudinal information in pattern recognitionLeon M Aksman, David J Lythgoe, Steven C R Williams, et al.
Psychopharmacology|August 25, 2018
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophreniaGrant McQueen, John Lally, Tracy Collier, et al.
Schizophrenia Research|January 10, 2022
Relationship between cortical glutamatergic metabolite levels and hippocampal activity in schizotypyYong-Ming Wang, Alice Egerton, Katrina McMullen, et al.
Frontiers in Psychiatry|October 7, 2022
Variants in the zinc transporter-3 encoding gene (SLC30A3) in schizophrenia and bipolar disorder: Effects on brain glutamate-A pilot studyLuke A Jelen, Mark S Green, Sinead King, et al.
Progress in Nuclear Magnetic Resonance Spectroscopy|June 3, 2021
Silent zero TE MR neuroimaging: Current state-of-the-art and future directionsEmil Ljungberg, Nikou L Damestani, Tobias C Wood, et al.
Human Brain Mapping|June 29, 2026
Test-Retest Reliability of Sensorimotor Activity Measured With Spinal Cord fMRIOlivia S Kowalczyk, Sonia Medina, Alessandra Venezia, et al.
NMR in Biomedicine|January 29, 2020
In vivo Glx and Glu measurements from GABA-edited MRS at 3 TTiffany Bell, Elodie S Boudes, Rachelle S Loo, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Trials|March 18, 2016
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trialAlexander Häge, Tobias Banaschewski, Jan K Buitelaar, et al.
Biological Psychiatry|February 4, 2019
Hyperperfusion of Frontal White and Subcortical Gray Matter in Autism Spectrum DisorderBradley S Peterson, Ariana Zargarian, Jarod B Peterson, et al.
Human Brain Mapping|February 10, 2024
Spinal fMRI demonstrates segmental organisation of functionally connected networks in the cervical spinal cord: A test-retest reliability studyOlivia S Kowalczyk, Sonia Medina, Dimitra Tsivaka, et al.
Human Brain Mapping|July 26, 2016
Making use of longitudinal information in pattern recognitionLeon M Aksman, David J Lythgoe, Steven C R Williams, et al.
Psychopharmacology|August 25, 2018
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophreniaGrant McQueen, John Lally, Tracy Collier, et al.
Schizophrenia Research|January 10, 2022
Relationship between cortical glutamatergic metabolite levels and hippocampal activity in schizotypyYong-Ming Wang, Alice Egerton, Katrina McMullen, et al.
Frontiers in Psychiatry|October 7, 2022
Variants in the zinc transporter-3 encoding gene (SLC30A3) in schizophrenia and bipolar disorder: Effects on brain glutamate-A pilot studyLuke A Jelen, Mark S Green, Sinead King, et al.
Progress in Nuclear Magnetic Resonance Spectroscopy|June 3, 2021
Silent zero TE MR neuroimaging: Current state-of-the-art and future directionsEmil Ljungberg, Nikou L Damestani, Tobias C Wood, et al.
Human Brain Mapping|June 29, 2026
Test-Retest Reliability of Sensorimotor Activity Measured With Spinal Cord fMRIOlivia S Kowalczyk, Sonia Medina, Alessandra Venezia, et al.
NMR in Biomedicine|January 29, 2020
In vivo Glx and Glu measurements from GABA-edited MRS at 3 TTiffany Bell, Elodie S Boudes, Rachelle S Loo, et al.
Pageof 10